Global Cord Blood Corp.
NYSE:
CO
Global Cord Blood Corp. is a life sciences enterprise dedicated to the storage of umbilical cord blood stem cells. Leveraging the rapid developments in life sciences research, and the increasing popularity and continuous new developments of clinical applications using stem cells, the Company endeavors to provide umbilical cord blood storage services for parents to save cord blood stem cells on behalf of their children, in China and the Asia Pacific regions, to safeguard the lives and health of their newborns. Global Cord Blood Corporation is the first cord blood banking operator approved by the Ministry of Health (MOH, now recognized as National Health Commission, or NHC), the People's Republic of China, to engage in the cord blood banking business. Global Cord Blood Corporation provides cord blood storage services in Beijing Municipality, Guangdong Province and Zhejiang Province. Global Cord Blood Corporation is also the largest cord blood banking operator in China, and is one of the founders of the highly recognized non-profit organization - AsiaCORD (Asia Cord Blood Bank) Organization.
Key Facts
Auditor
Public Listing
Domicile
HQ/Management
Location of Key Operations
IR Contact
KPMG Huazhen LLP
IPO (November 18, 2009)
Cayman Islands
Hong Kong
Internal
852-3605-8180
Analyst Coverage
Latest News
June 28, 2021: Global Cord Blood Corporation Reports Financial Result for the Fourth Quarter and Full Year of Fiscal 2021
June 22, 2021: Global Cord Blood Corporation to Report Fourth Quarter nd Full Year Fiscal 2021 Financial Results
March 15, 2021: Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
March 2, 2021: Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Aqcuisition Proposal
February 25, 2021: Global Cord Blood Corp. to Host Earnings Call
February 24, 2021: Global Cord Blood Corporation Reports Financial Results
February 19, 2021: Global Cord Blood Corporation to Report Third Quarter
February 11, 2021: Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal
January 5, 2021: Global Cord Blood Announces NHC Policy Update